France· FR:66032721

OLIMEL N9E, émulsion pour perfusion

A medicinal product containing acide aspartique + alanine + chlorure de potassium + acétate de lysine + 21 more, registered in France by BAXTER, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about acide aspartique + alanine + chlorure de potassium + acétate de lysine + 21 moreAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: ACIDE ASPARTIQUE + ALANINE + CHLORURE DE POTASSIUM + ACÉTATE DE LYSINE + 21 more
Manufacturer: BAXTER
Country: France (FR)
ATC code: —
Reimbursed: Yes
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 3

3 priced

cip13
3400938661316
6 poches Ã 3 compartiments polypropylÃ¨ne polyÃ©thylÃ¨ne SEBS : styrÃ¨ne-Ã©thylÃ¨ne-butylÃ¨ne-styrÃ¨ne EVA : Ã©thylÃ¨ne vinyl acÃ©tate copolymÃ¨re PCCE poly(cyclohexylÃ¨ne dimethylÃ¨ne) cyclohexane dicarboxylate/tÃ©tramÃ©thylglycol suremballÃ©e(s)/surpochÃ©e(s) de 1000 ml
EUR 145.05
cip13
3400938661484
4 poches Ã 3 compartiments polypropylÃ¨ne polyÃ©thylÃ¨ne SEBS : styrÃ¨ne-Ã©thylÃ¨ne-butylÃ¨ne-styrÃ¨ne EVA : Ã©thylÃ¨ne vinyl acÃ©tate copolymÃ¨re PCCE poly(cyclohexylÃ¨ne dimethylÃ¨ne) cyclohexane dicarboxylate/tÃ©tramÃ©thylglycol suremballÃ©e(s)/surpochÃ©e(s) de 1500 ml
EUR 112.9
cip13
3400938661545
4 poches Ã 3 compartiments polypropylÃ¨ne polyÃ©thylÃ¨ne SEBS : styrÃ¨ne-Ã©thylÃ¨ne-butylÃ¨ne-styrÃ¨ne EVA : Ã©thylÃ¨ne vinyl acÃ©tate copolymÃ¨re PCCE poly(cyclohexylÃ¨ne dimethylÃ¨ne) cyclohexane dicarboxylate/tÃ©tramÃ©thylglycol suremballÃ©e(s)/surpochÃ©e(s) de 2000 ml
EUR 123.92

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ff37e347-bf99-43ec-ba67-3dbcbf9a08c8
GET /v1/drugs/ff37e347-bf99-43ec-ba67-3dbcbf9a08c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66032721",
  "date_amm": "2008-07-21",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "ACIDE ASPARTIQUE + ALANINE + CHLORURE DE POTASSIUM + ACÉTATE DE LYSINE + 21 more",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "émulsion pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about acide aspartique + alanine + chlorure de potassium + acétate de lysine + 21 more.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console